WO2010045617A9 - Détection d'anomalies génétiques - Google Patents

Détection d'anomalies génétiques Download PDF

Info

Publication number
WO2010045617A9
WO2010045617A9 PCT/US2009/061096 US2009061096W WO2010045617A9 WO 2010045617 A9 WO2010045617 A9 WO 2010045617A9 US 2009061096 W US2009061096 W US 2009061096W WO 2010045617 A9 WO2010045617 A9 WO 2010045617A9
Authority
WO
WIPO (PCT)
Prior art keywords
genetic abnormalities
detecting genetic
compositions
present
methods
Prior art date
Application number
PCT/US2009/061096
Other languages
English (en)
Other versions
WO2010045617A2 (fr
Inventor
Aoy Tomita Mitchell
Michael Mitchell
Original Assignee
University Of Louisville Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Louisville Research Foundation filed Critical University Of Louisville Research Foundation
Publication of WO2010045617A2 publication Critical patent/WO2010045617A2/fr
Publication of WO2010045617A9 publication Critical patent/WO2010045617A9/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PCT/US2009/061096 2008-10-17 2009-10-16 Détection d'anomalies génétiques WO2010045617A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10643508P 2008-10-17 2008-10-17
US61/106,435 2008-10-17

Publications (2)

Publication Number Publication Date
WO2010045617A2 WO2010045617A2 (fr) 2010-04-22
WO2010045617A9 true WO2010045617A9 (fr) 2010-08-26

Family

ID=42107299

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/061096 WO2010045617A2 (fr) 2008-10-17 2009-10-16 Détection d'anomalies génétiques

Country Status (1)

Country Link
WO (1) WO2010045617A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
EP2029779A4 (fr) 2006-06-14 2010-01-20 Living Microsystems Inc Utilisation de génotypage snp fortement parallèle pour diagnostic fétal
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US20110312503A1 (en) 2010-01-23 2011-12-22 Artemis Health, Inc. Methods of fetal abnormality detection
EP2572003A4 (fr) 2010-05-18 2016-01-13 Natera Inc Procédés de classification de ploïdie prénatale non invasive
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
JP6153874B2 (ja) 2011-02-09 2017-06-28 ナテラ， インコーポレイテッド 非侵襲的出生前倍数性呼び出しのための方法
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
RU2717641C2 (ru) 2014-04-21 2020-03-24 Натера, Инк. Обнаружение мутаций и плоидности в хромосомных сегментах
EP3294906B1 (fr) 2015-05-11 2024-07-10 Natera, Inc. Procédés pour la détermination de la ploïdie
US11485996B2 (en) 2016-10-04 2022-11-01 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
US12084720B2 (en) 2017-12-14 2024-09-10 Natera, Inc. Assessing graft suitability for transplantation
JP2021520816A (ja) 2018-04-14 2021-08-26 ナテラ， インコーポレイテッド 循環腫瘍ｄｎａの個別化された検出を用いる癌検出およびモニタリングの方法
US11525159B2 (en) 2018-07-03 2022-12-13 Natera, Inc. Methods for detection of donor-derived cell-free DNA

Also Published As

Publication number Publication date
WO2010045617A2 (fr) 2010-04-22

Similar Documents

Publication Publication Date Title
WO2010045617A9 (fr) Détection d'anomalies génétiques
WO2012019198A3 (fr) Systèmes de dosage pour analyse génétique
CY1124494T1 (el) Μεθοδοι για τον προσδιορισμο του κλασματος εμβρυικων νουκλεϊκων οξεων σε μητρικα δειγματα
WO2010033639A9 (fr) Procédés et compositions pour enrichissement basé sur la méthylation en acide nucléique foetal dans un échantillon maternel, utiles pour les diagnostics prénatals non invasifs
WO2008094902A3 (fr) Compositions et procedes de detection d'acide nucleique par le biais d'une reaction de clivage
HK1222413A1 (zh) 由母本生物樣品鑒定新生胎兒突變
EP2569453A4 (fr) Méthodes d'isolement de l'acide nucléique
WO2009015863A3 (fr) Procédés d'identification faisant appel à la méthylation de cpg
WO2009048530A3 (fr) Dosages à base de particules hautement multiplexées
WO2009114543A3 (fr) Tests adn pour déterminer le sexe d'un bébé avant sa naissance
NZ601079A (en) Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies
WO2008024473A3 (fr) Cartographie d'interactions génomiques
IN2015MN00457A (fr)
NZ582702A (en) Diagnosing fetal chromosomal aneuploidy using genomic sequencing
TW200700558A (en) A method for the detection of chromosomal aneuploidies
EP2294225B8 (fr) Procédé d'amplification directe à partir d'échantillons bruts d'acides nucléiques
WO2009049916A3 (fr) Procédé de détermination de la présence d'une méthylation des résidus cytosine
WO2007146819A3 (fr) Procédés d'identification et d'utilisation d'échantillons constants pnu
IL228971B (en) Preparations and methods for the detection and identification of nucleic acid sequences in biological samples
EP3955004A3 (fr) Utilisation d'acides gras dans des procedes de detection de cancer
WO2007132166A3 (fr) Nouveaux marqueurs de méthylation fœtaux
WO2013132305A8 (fr) Analyse basée sur la taille de fraction d'adn fœtal dans le plasma maternel
WO2009129505A3 (fr) Compositions, procédé et trousses utilisant des sondes synthétiques pour déterminer la présence d'un acide nucléique voulu
WO2010135574A3 (fr) Systèmes et méthodes de détermination du pourcentage d'hémoglobine glyquée
WO2010084154A3 (fr) Détermination du degré de méthylation de l'adn

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09821366

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct app. not ent. europ. phase

Ref document number: 09821366

Country of ref document: EP

Kind code of ref document: A2